SI1115725T1 - Tetrahydropyridoethers - Google Patents

Tetrahydropyridoethers

Info

Publication number
SI1115725T1
SI1115725T1 SI9930207T SI9930207T SI1115725T1 SI 1115725 T1 SI1115725 T1 SI 1115725T1 SI 9930207 T SI9930207 T SI 9930207T SI 9930207 T SI9930207 T SI 9930207T SI 1115725 T1 SI1115725 T1 SI 1115725T1
Authority
SI
Slovenia
Prior art keywords
tetrahydropyridoethers
naphthyridine
imidazo
methoxyethoxy
tetrahydro
Prior art date
Application number
SI9930207T
Other languages
English (en)
Slovenian (sl)
Inventor
Stefan Postius
Wolfgang-Alexander Simon
Gerhard Grundler
Guido Hanauer
Reinhard Huber
Wolfgang Kromer
Ernst Sturm
J�rg SENN-BILFINGER
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of SI1115725T1 publication Critical patent/SI1115725T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SI9930207T 1998-09-23 1999-09-17 Tetrahydropyridoethers SI1115725T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19843504 1998-09-23
EP98117988 1998-09-23
PCT/EP1999/006899 WO2000017200A1 (fr) 1998-09-23 1999-09-17 Tetrahydropyridoethers
EP99948776A EP1115725B1 (fr) 1998-09-23 1999-09-17 Tetrahydropyridoethers

Publications (1)

Publication Number Publication Date
SI1115725T1 true SI1115725T1 (en) 2003-06-30

Family

ID=26049024

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930207T SI1115725T1 (en) 1998-09-23 1999-09-17 Tetrahydropyridoethers

Country Status (31)

Country Link
US (4) US6436953B1 (fr)
EP (1) EP1115725B1 (fr)
JP (1) JP4145492B2 (fr)
KR (1) KR100668400B1 (fr)
CN (2) CN100506821C (fr)
AT (1) ATE231862T1 (fr)
AU (1) AU763463B2 (fr)
BG (1) BG65195B1 (fr)
BR (1) BR9914044A (fr)
CA (1) CA2344251A1 (fr)
CZ (1) CZ292335B6 (fr)
DE (1) DE69905178T2 (fr)
DK (1) DK1115725T3 (fr)
EA (1) EA005377B1 (fr)
EE (1) EE04677B1 (fr)
ES (1) ES2191464T3 (fr)
GE (1) GEP20032926B (fr)
HK (1) HK1038360B (fr)
HR (1) HRP20010224A2 (fr)
HU (1) HUP0102990A3 (fr)
ID (1) ID28896A (fr)
IL (2) IL142063A0 (fr)
NO (1) NO317304B1 (fr)
NZ (1) NZ510610A (fr)
PL (1) PL193616B1 (fr)
PT (1) PT1115725E (fr)
RS (1) RS50145B (fr)
SI (1) SI1115725T1 (fr)
SK (1) SK285165B6 (fr)
TR (1) TR200100805T2 (fr)
WO (1) WO2000017200A1 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1115725T3 (da) 1998-09-23 2003-06-23 Altana Pharma Ag Tetrahydropyridoethere
ATE240956T1 (de) * 1999-04-17 2003-06-15 Altana Pharma Ag Haloalkoxy-imidazonaphthyridine
CA2285516C (fr) * 1999-05-12 2010-12-07 President And Fellows Of Harvard College Agents d'imagerie pour transporteur de dopamine
MXPA02009549A (es) * 2000-03-29 2004-05-14 Altana Pharma Ag Imidazopiridinas triciclicas.
EP1313740B1 (fr) * 2000-03-29 2005-11-30 ALTANA Pharma AG Promedicaments de derives d'imidazopyridine
SK5072003A3 (en) 2000-10-25 2003-09-11 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
JP2004520422A (ja) * 2001-03-08 2004-07-08 アストラゼネカ・アクチエボラーグ 新しい用途
CA2452802A1 (fr) 2001-08-02 2003-02-20 Altana Pharma Ag Epoxydes tricycliques
JP2005504048A (ja) * 2001-08-03 2005-02-10 アルタナ　ファルマ　アクチエンゲゼルシャフト 胃腸障害治療用のアルカリ置換されたイミダゾピリジン
EP1417208A1 (fr) * 2001-08-03 2004-05-12 ALTANA Pharma AG Imidazopyridines amino-substituees destinees au traitement de maladies gastro-intestinales
AU2003206879A1 (en) 2002-02-15 2003-09-04 Altana Pharma Ag Tricyclic n-acyl compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CA2484272A1 (fr) * 2002-05-07 2003-11-20 Altana Pharma Ag Nouvelle combinaison destinee au traitement des troubles des voies aeriennes
JP2006508142A (ja) 2002-11-19 2006-03-09 アルタナ　ファルマ　アクチエンゲゼルシャフト ８−置換イミダゾピリジン
JP4755495B2 (ja) 2002-12-12 2011-08-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 組合せ医薬品
CN1726031A (zh) * 2002-12-20 2006-01-25 奥坦纳医药公司 8－三烷基硅氧基－2－甲基－9－苯基－7－氧代－7,8,9,10－四氢咪唑并[1,2－h][1,7]二氮杂萘
EP1599175A2 (fr) * 2003-02-17 2005-11-30 ALTANA Pharma AG Combinaisons contenant des imidazopyridines tricycliques et leur utilisation pour traiter des maladies gastrointestinales et inflammatoires
PT1606261E (pt) 2003-03-10 2010-01-11 Nycomed Gmbh Novo processo para a preparação de roflumilast
TW200503783A (en) * 2003-04-11 2005-02-01 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
SA04250092B1 (ar) * 2003-05-14 2008-05-04 التانا فاروا ايه جي مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
WO2004105795A1 (fr) * 2003-05-27 2004-12-09 Altana Pharma Ag Combinaisons pharmaceutiques d'un inhibiteur de la pompe a protons et d'un compose modifiant la motilite gastro-intestinale
WO2005021040A2 (fr) * 2003-08-29 2005-03-10 Dynogen Pharmaceuticals, Inc. Compositions utiles pour le traitement de troubles de motilite gastro-intestinale
EP1670482B2 (fr) 2003-09-16 2022-06-29 Covis Pharma B.V. Utilisation de ciclesonide dans le traitement de maladies respiratoires
EP1974730A1 (fr) 2003-11-03 2008-10-01 AstraZeneca AB Dérivés d'imidazo[1,2-a]pyridine pour l'utilisation dans le traitement des troubles du sommeil provoqués par un reflux gastro-oesophagien silencieux
AU2004298453A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
AR047605A1 (es) * 2004-02-17 2006-01-25 Altana Pharma Ag Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos.
MX2007002219A (es) 2004-09-03 2007-05-04 Yuhan Corp Derivados de pirrolo [3,2-b ] piridina y procesos para su preparacion.
BRPI0514843A (pt) 2004-09-03 2008-06-24 Yuhan Corp derivados de pirrolo[3,2-c] piridina e processos para a preparação dos mesmos
WO2006025716A1 (fr) 2004-09-03 2006-03-09 Yuhan Corporation Derives de pyrrolo[2,3-c]pyridine et leurs procedes de preparation
CA2601250C (fr) * 2005-03-16 2014-10-28 Nycomed Gmbh Forme posologique a gout masque
EP2080513A1 (fr) * 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tétrahydropyridoéthers pour le traitement de la DMA
WO2011004882A1 (fr) 2009-07-09 2011-01-13 ラクオリア創薬株式会社 Antagoniste de la pompe à acide destiné au traitement de maladies associées à un transit gastro-intestinal anormal
WO2012027240A1 (fr) * 2010-08-23 2012-03-01 Schering Corporation Inhibiteurs tricycliques fusionnés de la cible de la rapamycine chez les mammifères
WO2013187727A1 (fr) * 2012-06-15 2013-12-19 Bio-Pharm Solutions Co., Ltd. Composé de sulfamate de phénylalkyle et composition myorelaxante le contenant
WO2015052256A1 (fr) 2013-10-08 2015-04-16 Katairo Gmbh Tétrahydropyridoéthers pour le traitement de la maladie de stargardt

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
CA1327796C (fr) 1987-07-16 1994-03-15 Jorg Senn-Bilfinger Diazoles
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
AU702166B2 (en) * 1994-07-28 1999-02-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Acylimidazopyridines
WO1998042707A1 (fr) * 1997-03-24 1998-10-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Composes de tetrahydropyrido
IL131407A0 (en) * 1997-03-24 2001-01-28 Byk Gulden Lomberg Chem Fab Tetrahydropyrido compounds medicaments containing the same and the use thereof
DK1115725T3 (da) 1998-09-23 2003-06-23 Altana Pharma Ag Tetrahydropyridoethere

Also Published As

Publication number Publication date
US7105676B2 (en) 2006-09-12
SK3992001A3 (en) 2001-12-03
ES2191464T3 (es) 2003-09-01
HUP0102990A3 (en) 2002-09-30
AU763463B2 (en) 2003-07-24
WO2000017200A1 (fr) 2000-03-30
PL346617A1 (en) 2002-02-25
US6436953B1 (en) 2002-08-20
IL142063A (en) 2007-10-31
KR100668400B1 (ko) 2007-01-17
CN1560055A (zh) 2005-01-05
PL193616B1 (pl) 2007-02-28
EP1115725B1 (fr) 2003-01-29
HRP20010224A2 (en) 2002-04-30
EP1115725A1 (fr) 2001-07-18
EA200100315A1 (ru) 2001-10-22
HK1038360B (zh) 2003-05-16
RS50145B (sr) 2009-03-25
CA2344251A1 (fr) 2000-03-30
GEP20032926B (en) 2003-03-25
ID28896A (id) 2001-07-12
HUP0102990A2 (hu) 2002-01-28
CN100506821C (zh) 2009-07-01
AU6192099A (en) 2000-04-10
CN1319101A (zh) 2001-10-24
CZ20011082A3 (cs) 2001-09-12
DK1115725T3 (da) 2003-06-23
ATE231862T1 (de) 2003-02-15
JP4145492B2 (ja) 2008-09-03
BG105270A (en) 2001-11-30
CZ292335B6 (cs) 2003-09-17
NO20011243D0 (no) 2001-03-12
YU21401A (sh) 2004-03-12
IL142063A0 (en) 2002-03-10
HK1038360A1 (en) 2002-03-15
BR9914044A (pt) 2001-12-04
NZ510610A (en) 2003-07-25
EE04677B1 (et) 2006-08-15
EA005377B1 (ru) 2005-02-24
US20040162310A1 (en) 2004-08-19
EE200100172A (et) 2002-06-17
TR200100805T2 (tr) 2001-08-21
US20020169320A1 (en) 2002-11-14
BG65195B1 (bg) 2007-06-29
NO20011243L (no) 2001-03-12
DE69905178T2 (de) 2003-07-17
DE69905178D1 (de) 2003-03-06
US6696460B2 (en) 2004-02-24
CN1155598C (zh) 2004-06-30
NO317304B1 (no) 2004-10-04
SK285165B6 (sk) 2006-07-07
US7393860B1 (en) 2008-07-01
KR20010075223A (ko) 2001-08-09
PT1115725E (pt) 2003-06-30
JP2002526499A (ja) 2002-08-20

Similar Documents

Publication Publication Date Title
HK1038360A1 (en) Tetrahydropyridoethers
HK1048122A1 (en) Method for the preparation of citalopram.
ZA200108855B (en) Method for the preparation of citalopram.
ZA200108854B (en) Method for the preparation of citalopram.
EE04676B1 (et) Imidasopridiini derivaadid, mis inhibeerivad maohappesekretsiooni, protsess nende valmistamiseks ning nende kasutamine
HK1042297A1 (en) Method for the preparation of citalopram
GB2360281B (en) Method for the preparation of citalopram
HK1043130A1 (en) Method for the preparation of 5-cyanophthalide.
HK1044342A1 (en) Method for the preparation of 5-cyanophthalide.
HK1054378A1 (en) Method for the preparation of citalopram.
ZA200106683B (en) Method for the preparation of citalopram.
HK1052702A1 (en) Method for the preparation of 5-carboxyphthalide.
ZA99493B (en) Method for the isolation of nucleic acid.
CY2392B1 (en) Method for the preparation of alpha-bromolactam derivatives.
EP0669361A3 (fr) Procédé de préparation de polyhétérosiloxanes.
HK1043129B (zh) 西酞普蘭的製備方法
ZA973400B (en) Method for the manufacture of brushes.
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
ZA200102822B (en) Method for the preparation of citalopram.
ZA200106687B (en) Method for the preparation of citalopram.
AUPQ075599A0 (en) Method for direct electromagnetic-ultrasonic measurements of the permeability ofrocks
SI1123284T1 (en) Method for the preparation of citalopram
ZA99354B (en) Method of making sulfanatophenyl substituted porphines.